BRD4 inhibition and FXR activation, individually beneficial in cholestasis, are antagonistic in combination

Activation of farnesoid X receptor (FXR) by obeticholic acid (OCA) reduces hepatic inflammation and fibrosis in patients with primary biliary cholangitis (PBC), a life-threatening cholestatic liver failure. Inhibition of bromodomain-containing protein 4 (BRD4) also has antiinflammatory, antifibrotic...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Hyunkyung Jung, Jinjing Chen, Xiangming Hu, Hao Sun, Shwu-Yuan Wu, Cheng-Ming Chiang, Byron Kemper, Lin-Feng Chen, Jongsook Kim Kemper
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	American Society for Clinical investigation 2021-01-01
Edice:	JCI Insight
Témata:	Hepatology Inflammation
On-line přístup:	https://doi.org/10.1172/jci.insight.141640
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!